These data indicate that heparan compounds inhibit S. pneumoniae corneal infection by interfering with S. pneumoniae adhesion onto FN fibrils in the subepithelial ECM exposed by injury. The gene discussed is FN1; the disease is susceptibility to pneumonia measurement.